Between 2024 and 2028, Italy's forecasted import of vaccines for human use shows a steady upward trend. Starting from $715.66 million in 2024 and reaching $797.24 million by 2028, this suggests modest year-on-year growth. The year-on-year growth rates are approximately 2.94% for 2025, 2.79% for 2026, 2.66% for 2027, and 2.55% for 2028. The Compound Annual Growth Rate (CAGR) for this five-year period is around 2.74%.
Future trends to watch for include advancements in vaccine technology and possible policy changes in global vaccine distribution. Additionally, tracking emerging health challenges and demographic shifts within Italy will be crucial in forecasting future vaccine import needs.
